Browse Title Index
| Issue | Title | |
| Vol 6, No 2 (2015) | The highlights of the 9th Polish Conference post-ASH (American Society of Hematology) | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha | ||
| Vol 7, No 2 (2016) | The highlights of the lymphoid malignancies on the Annual Meeting of the American Society of Clinical Oncology 2016 | Abstract PDF (Polish) HTML (Polish) |
| Ewa Kalinka-Warzocha | ||
| Vol 2, Supp. B (2011) | The history of treatment of chronic myeloid leukemia | Abstract PDF (Polish) |
| Tomasz Sacha | ||
| Vol 10, Supp. B (2019) | The impact of azacitidine on improvement of quality of life in patients in venerable age with intermediate-2 risk group of myelodysplastic syndrome | Abstract PDF (Polish) |
| Judyta Strzała, Wojciech Baran | ||
| Vol 10, No 1 (2019) | The importance of neprilysin (CD10) in hematooncology | Abstract PDF (Polish) |
| Kamil Sokół, Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz | ||
| Vol 4, No 3 (2013) | The infl uence of glucose metabolism on diagnosis and treatment of myeloid and lymphoid malignancies | Abstract PDF (Polish) HTML (Polish) |
| Agata Malenda, Dominika Anna Nowis | ||
| Vol 3, No 4 (2012) | The isolated extramedullary breast relapse in patient with inv(16)(p13;q22) and CBFB-MYH11 acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation — case report and review of the literature | Abstract PDF (Polish) |
| Anna Szumera-Ciećkiewicz, Barbara Nasiłowska-Adamska, Monika Prochorec-Sobieszek, Katarzyna Borg, Joanna Sawczuk-Chabin, Bożena Mariańska, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 9, No 1 (2018) | The most important changes in the diagnosis of aggressive B cell lymphomas according to the World Health Organization 2017 classification | Abstract PDF (Polish) |
| Anna Szumera-Ciećkiewicz, Monika Prochorec-Sobieszek | ||
| Vol 6, No 2 (2015) | The optimal first-line regimen for patients with follicular lymphoma in 2015 | Abstract PDF (Polish) HTML (Polish) |
| Iwona Hus | ||
| Vol 2, No 1 (2011) | The perspectives of the targeted therapy in acute myeloid leukemia | Abstract PDF (Polish) |
| Sebastian Grosicki | ||
| Vol 10, Supp. A (2019) | The problem of leukocytosis control in a patient with primary myelofibrosis treated with ruxolitinib | Abstract PDF (Polish) |
| Marta Sobas, Anna Czyż, Krzysztof Zduniak, Monika Biedroń, Tomasz Wróbel | ||
| Vol 5, No 4 (2014) | The problem of treatment failure of tyrosine kinase inhibitors and interferon alfa in chronic myelogenous leukemia without mutations in the BCR-ABL1 gene — a 27-year-old woman case | Abstract PDF (Polish) HTML (Polish) |
| Marek Kriegler, Anna Jaśkowiec, Olga Haus, Sebastian Grosicki | ||
| Vol 2, No 2 (2011) | The relations between therapy results and accepted evaluation criteria of progression free survival and event free survival — analysis on the basis of tyrosine kinase inhibitors use in patients with chronic myeloid leukemia | Abstract PDF (Polish) |
| Krzysztof Lewandowski | ||
| Vol 5, No 4 (2014) | The role of bendamustine in chronic lymphocytic leukemia with particular focus on the treatment of elderly patients | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Warzocha, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska, Marek Dudziński, Dariusz Wołowiec, Andrzej Pluta, Sławomira Kyrcz-Krzemień, Iwona Hus, Tadeusz Robak | ||
| Vol 10, Supp. C (2019) | The role of brentuximab vedotin in the treatment of patients with refractory/relapsed Hodgkin lymphoma based on two case reports | Abstract PDF (Polish) |
| Monika Chełstowska, Krzysztof Jamroziak, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 10, No 2 (2019) | The role of brentuximab vedotin in the treatment of patients with refractory/relapsed Hodgkin lymphoma based on two case reports | Abstract PDF (Polish) |
| Monika Chełstowska, Krzysztof Jamroziak, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 8, No 4 (2017) | The role of daratumumab in the treatment of patients with relapsed/refractory plasma cell myeloma | Abstract PDF (Polish) |
| Aleksander Salomon Perzyński, Krzysztof Jamroziak | ||
| Vol 2, No 2 (2011) | The role of hematopoietic stem cell transplantation in the treatment of patients with plasma cell myeloma | Abstract PDF (Polish) |
| Maria Adamczyk-Cioch | ||
| Vol 8, No 4 (2017) | The role of hematopoietic stem cell transplantation in the treatment of patients with primary cutaneous lymphomas | Abstract PDF (Polish) |
| Włodzimierz Wojciech Mendrek | ||
| Vol 1, No 1 (2010) | The role of HLA disparity in hematopoietic stem cells transplantation | Abstract PDF (Polish) |
| Jacek Nowak | ||
| Vol 3, No 4 (2012) | The role of human leukocyte antigen G in immunological mechanisms and its clinical implication | Abstract PDF (Polish) |
| Gabriela Klimkiewicz-Wojciechowska, Ewa Lech-Marańda | ||
| Vol 7, No 3 (2016) | The role of idelalisib in the treatment of patients with chronic lymphocytic leukemia | Abstract PDF (Polish) |
| Bartosz Puła, Krzysztof Jamroziak, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 2, No 3 (2011) | The role of ofatumumab in the treatment of B-cell lymphomas | Abstract PDF (Polish) |
| Marek Dudziński | ||
| Vol 3, No 1 (2012) | The role of the high-dose chemotherapy supported by autologous hematopoietic stem cell transplantation in the therapeutic plan of patients with acute myeloid leukemia | Abstract PDF (Polish) |
| Sebastian Grosicki | ||
| Vol 8, No 1 (2017) | The role of venetoclax in the treatment of patients with chronic lymphocytic leukemia | Abstract PDF (Polish) HTML (Polish) |
| Bartosz Puła, Krzysztof Jamroziak | ||
| 451 - 475 of 543 Items | << < 14 15 16 17 18 19 20 21 22 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
